MedTrace Logo

Tranexamic Acid for the Latarjet Procedure.

NCT03458468 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2019-07-30

No results posted yet for this study

Summary

The investigators propose a double-blinded randomized study evaluating the effectiveness of tranexamic acid in reducing postoperative swelling and haematoma formation after the Latarjet procedure.

The purpose of this study is to assess the efficacy of tranexamic acid (TXA), given via intra-articular injection at the time of surgery in patients undergoing the Latarjet procedure for shoulder instability.

Conditions

  • Anterior Shoulder Instability

Interventions

DRUG

Tranexamic Acid

1g Tranexamic acid prior to skin incision

DRUG

Saline

Equivalent volume of saline prior to skin incision

Sponsors & Collaborators

  • Sports Surgery Clinic, Santry, Dublin

    lead OTHER

Principal Investigators

  • Hannan Mullett, FRCSI · Sports Surgery Clinic

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-01
Primary Completion
2019-03-01
Completion
2019-03-01

Countries

  • Ireland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03458468 on ClinicalTrials.gov